Evidence map›Paper›PMID 42371697›Full record

ReviewAdvanced materials (Deerfield Beach, Fla.)2026

Deciphering the Catalytic Mechanism of Oxidoreductase-Like Nanozymes Along the Reaction Pathway: Activity, Specificity and Sustainability.

Kaizheng Feng, Mingyu Zhang, Yitong Zhao, Guancheng Wang, Jingyuan Ma, Jiaming Wang, Xiaoli Wei, Haoan Wu, Ming Ma, Yu Zhang

Abstract readReview
In one paragraph

Review in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kaizheng FengState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Mingyu ZhangCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Yitong ZhaoState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Guancheng WangState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Jingyuan MaState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Jiaming WangState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Xiaoli WeiState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Haoan WuState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Ming MaState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
Yu ZhangState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-0228-7979

Funding

Frontier Technologies R&D Program of Jiangsu BF2024062National Key Research and Development Program of China 2022YFA1205802National Key Research and Development Program of China 2022YFC2406504National Natural Science Foundation of China 82302370National Natural Science Foundation of China 82572399Natural Science Foundation of Jiangsu Province BK20230836Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX24_0471SEU Innovation Capability Enhancement Plan for Doctoral Students CXJH_SEU 25140
6 · The paper itself

Abstract

As the most applied nanozymes, the catalytic mechanism of oxidoreductase (OR)-like nanomaterials has received widespread attention over the past decades. Despite of the large efforts, their catalytic mechanism is currently abundant but still complicated, which restricts further development. Rather than the common mechanistic discussion simply classified by material type or regulatory method, this review deepens the analysis on the catalytic mechanism of OR-like nanozymes through a detailed overview along their reaction pathways. The electron transfer sequence, substrate adsorption, reactive intermediate generation/transformation, and product desorption in the catalytic pathway of OR-like nanozymes are explicitly investigated and compared with their natural counterparts. The root causes that determine their catalytic activity, specificity, and sustainability are highlighted. Moreover, the superiority of the catalytic mechanism-tailored OR-like nanozymes in various applications is highlighted. Finally, the future prospects of catalytic mechanism research are outlined, providing inspiration for the catalytic pathway clarification, activity improvement, specificity exploration, mechanism study at actual scenarios, and machine learning integration. It is anticipated that this review will promote a thorough and consistent understanding on the catalytic mechanism of OR-like nanozymes.

Indexed as

NanostructuresOxidoreductasesCatalysisOxidoreductasescatalytic activitycatalytic mechanismoxidoreductase‐like nanozymesspecificitysustainability

Identifiers

PMID42371697
PMCPMC13432061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.